why choose us

Clinical Trials Search

Showing 13,830 of 132,963 result(s)
Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)

Status: Completed

Condition: OSA

Interventions: Oral administration at bedtime.

Date: 2023-03-31

Gastric Sleeve-Induced Weight Loss on Shortness of Breath in Obesity

Status: Completed

Condition: Dyspnea

Interventions: Gastric sleeve resection will be performed by experienced surgeons.
Postoperative care will follow UCLA's postoperative care pathways for ga

Date: 2023-03-31

Cognitive, Emotional, Communicative, and Motor Development in Children Born From IOC

Status: COMPLETED

Condition: ART

Interventions: . All mothers of children of born from cryopreserved oocytes will be contacted by phone and administered a questionnaire, to gather additional informa

Date: 2023-03-31

Neural Markers of Balance in Adults With Brain Injury

Status: COMPLETED

Condition: Brain Injuries

Interventions: Yoga is delivered as described in an earlier section in a group format.
Classes are an hour in duration and occur once per week for 8 weeks, and

Date: 2023-03-31

Clinical Trial of PM54 in Advanced Solid Tumors Patients.

Status: Completed

Condition: Advanced Solid Tumor

Interventions:

PM54 powder for concentrate for solution for infusion (3 mg;vial) is a sterile, preservative-free, lyophilized white to yellowish cake in a si

Date: 2023-03-31

Biological Sample Repository for Gastrointestinal Disorders

Status: Completed

Condition: Obesity

Interventions: Blood collection via venipuncture

Date: 2023-03-31

Extracellular Vesicles as Potential Biomarkers and Therapeutic Target in Gaucher Disease

Status: Completed

Condition: Gaucher Disease

Interventions: no intervention, this is an observational study

Date: 2023-03-31

Clinical Utility of MyProstateScore 2.0 P2

Status: Completed

Condition: Prostate Cancer

Interventions: A diagnostic test for the likelihood of finding clinically significant cancer from a prostate biopsy.

Date: 2023-03-31

Comparative Study of Rosuvastatin;Ezetimib 20;10 mg and Atovastatin;Ezetimib 40;10 mg

Status: Completed

Condition: Coronary Artery Disease

Interventions:

In randomization, 100 patients will proceed with Rosuvastatin;Ezetimib 20;10 mg and 100 patients will proceed with Atovastatin;Ezeti

Date: 2023-03-31